Les antirétroviraux au Botswana. Observatoire des mutations de l'intervention internationale sur la santé en Afrique
</titre> By focusing on access to free antiretroviral treatments in Botswana, this article analyses recent transformations of international cooperation on health issues. The partnership between the government of Botswana, the pharmaceutical company Merck & Co and the Bill and Melinda Gates Foundation was made possible through pre-existing biomedical collaboration between the government of Botswana and the Harvard School of Public Health. This configuration of actors and interests offers a vantage point of contemporary global health partnerships in which philanthropy, science and public health overlap. Most often determined by their convenience, accessibility and chance of success, global health interventions tend to reproduce inequalities within health systems and on a global level.
Year of publication: |
2013
|
---|---|
Authors: | Chabrol, Fanny |
Published in: |
Revue Tiers-Monde. - Armand Colin. - Vol. n°215.2013, 3, p. 17-34
|
Publisher: |
Armand Colin |
Subject: | Aids | global health | Botswana | antiretrovirals | pharmceutical philanthropy | biomedical research |
Saved in:
Online Resource
Saved in favorites
Similar items by subject
-
Chabrol, Fanny, (2013)
-
Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments
Duggan, Mark, (2008)
-
Homar, Franc, (2012)
- More ...
Similar items by person